Works by Mita, Monica M.


Results: 17
    1

    Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
    By:
    • Chia-Chi Lin;
    • Calvo, Emiliano;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Sarantopoulos, John;
    • Mita, Alain C.;
    • Preston, Glenn G.;
    • Mita, Monica M.;
    • Rodon, Jordi;
    • Mays, Theresa;
    • I.-Tien Yeh;
    • O'Rourke, Pat;
    • Takimoto, Chris H.;
    • Dancey, Janet E.;
    • Chen, Helen;
    • Tolcher, Anthony W.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

    Published in:
    2017
    By:
    • Mita, Monica M;
    • Mita, Alain C;
    • Moseley, Jennifer L;
    • Poon, Jennifer;
    • Small, Karen A;
    • Jou, Ying-Ming;
    • Kirschmeier, Paul;
    • Zhang, Da;
    • Zhu, Yali;
    • Statkevich, Paul;
    • Sankhala, Kamelesh K;
    • Sarantopoulos, John;
    • Cleary, James M;
    • Chirieac, Lucian R;
    • Rodig, Scott J;
    • Bannerji, Rajat;
    • Shapiro, Geoffrey I
    Publication type:
    journal article
    8
    9
    10

    Statins and pancreatic cancer (Review).

    Published in:
    Oncology Letters, 2017, v. 13, n. 3, p. 1035, doi. 10.3892/ol.2017.5572
    By:
    • JUN GONG;
    • SACHDEV, ESHA;
    • ROBBINS, LORI A.;
    • LIN, EMILY;
    • HENDIFAR, ANDREW E.;
    • MITA, MONICA M.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17